San Francisco, California, March 22, 2018: The intensifying need for minimally invasive procedures for a wide range of gynecologic and obstetrical conditions in women is a key factor driving the demand for hysteroscopy instruments. The growing popularity of hysteroscopy as a minimally invasive surgical process for managing conditions related to excessive uterine bleeding, abortion, and infertility is boosting the market. A new report penned by TMR Research, titled, “Hysteroscopy Instruments Market: Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast 2017–2025”, sheds light on key growth dynamics, emerging trends, technological advances impacting the growth of the market. The study highlights lucrative avenues and the prevailing competitive landscape in various regions.
The global hysteroscopy instruments market is projected to rise at a healthy clip over the forecast period of 2017–2025. In various developing and developed countries, the market is increasingly driven by wide adoption of hysteroscopes for the safe and efficient diagnosis of intrauterine pathology.
The rising prevalence of common gynecologic disorders, especially in women of reproductive age, is a notable factor bolstering the demand for hysteroscopy instruments. The rising number of elderly women with gynecological diseases is also catalyzing the uptake. The popularly rising use of hysteroscopy in the diagnosis and treatment of adenomyosis is likely to accentuate the growth of the market.
Get Sample Copy of this Report @
The rising uptake of minimally invasive gynecological procedures is a notable factor expected to catalyze the market’s growth. Advent of advanced products is contributing to the overall revenue of the market. Constant clinical advances has enhanced the diagnostic and therapeutic efficiency of hysteroscopy, thereby unlocking exciting potential of the market.
Some of the key regional market could be the Middle East and Africa, North America, Asia Pacific, Europe, Latin America. Of these, North America is likely to collect attractive revenues over the forecast period, owing to a robust healthcare infrastructure.
Some of the players expected to hold a sizeable stake in the market are Ethicon, Inc., Hospiline Equipments Private Limited, Medicon, CooperSurgical Inc., and Hologic, Inc.